632 related articles for article (PubMed ID: 32445735)
1. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
[TBL] [Abstract][Full Text] [Related]
2. Clinical and metabolic characteristics of the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) randomised clinical trial cohort.
Zaghloul H; Chagoury O; Elhadad S; Hayder Ahmed S; Suleiman N; Al Naama A; El Nahas K; Al Hamaq A; Charlson M; Wells MT; Al Abdulla S; Abou-Samra AB; Taheri S
BMJ Open; 2020 Dec; 10(12):e041386. PubMed ID: 33293319
[TBL] [Abstract][Full Text] [Related]
3. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Stefanetti R; Trenell M; Welsh P; Kean S; Ford I; McConnachie A; Sattar N; Taylor R
Lancet; 2018 Feb; 391(10120):541-551. PubMed ID: 29221645
[TBL] [Abstract][Full Text] [Related]
4. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
Lean MEJ; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Welsh P; Kean S; Ford I; McConnachie A; Messow CM; Sattar N; Taylor R
Lancet Diabetes Endocrinol; 2019 May; 7(5):344-355. PubMed ID: 30852132
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial.
Taheri S; Chagoury O; Zaghloul H; Elhadad S; Ahmed SH; Omar O; Payra S; Ahmed S; El Khatib N; Amona RA; El Nahas K; Bolton M; Chaar H; Suleiman N; Jayyousi A; Zirie M; Janahi I; Elhag W; Alnaama A; Zainel A; Hassan D; Cable T; Charlson M; Wells M; Al-Hamaq A; Al-Abdulla S; Abou-Samra AB
Trials; 2018 May; 19(1):284. PubMed ID: 29784059
[TBL] [Abstract][Full Text] [Related]
6. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.
Ikramuddin S; Billington CJ; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Wang Q; Korner J
Lancet Diabetes Endocrinol; 2015 Jun; 3(6):413-422. PubMed ID: 25979364
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial.
Rubinstein A; Miranda JJ; Beratarrechea A; Diez-Canseco F; Kanter R; Gutierrez L; Bernabé-Ortiz A; Irazola V; Fernandez A; Letona P; Martínez H; Ramirez-Zea M;
Lancet Diabetes Endocrinol; 2016 Jan; 4(1):52-63. PubMed ID: 26653067
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an adapted version of the Diabetes Prevention Program for low- and middle-income countries: A cluster randomized trial to evaluate "Lifestyle Africa" in South Africa.
Catley D; Puoane T; Tsolekile L; Resnicow K; Fleming KK; Hurley EA; Smyth JM; Materia FT; Lambert EV; Vitolins MZ; Levitt NS; Goggin K
PLoS Med; 2022 Apr; 19(4):e1003964. PubMed ID: 35427357
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.
Quist JS; Pedersen HE; Jensen MM; Clemmensen KKB; Bjerre N; Ekblond TS; Uldal S; Størling J; Wewer Albrechtsen NJ; Holst JJ; Torekov SS; Nyeland ME; Vistisen D; Jørgensen ME; Panda S; Brock C; Finlayson G; Blond MB; Færch K
Lancet Healthy Longev; 2024 May; 5(5):e314-e325. PubMed ID: 38588687
[TBL] [Abstract][Full Text] [Related]
10. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
[TBL] [Abstract][Full Text] [Related]
12. Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial.
Johansen MY; Karstoft K; MacDonald CS; Hansen KB; Ellingsgaard H; Hartmann B; Wewer Albrechtsen NJ; Vaag AA; Holst JJ; Pedersen BK; Ried-Larsen M
Diabetologia; 2020 Nov; 63(11):2410-2422. PubMed ID: 32816096
[TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L; Zhang Y; Shen S; Wang X; Dong L; Li Q; Ren W; Li Y; Bai J; Gong Q; Kuang H; Qi L; Lu Q; Cheng W; Liu Y; Yan S; Wu D; Fang H; Hou F; Wang Y; Yang Z; Lian X; Du J; Sun N; Ji L; Li G;
Lancet Diabetes Endocrinol; 2023 Aug; 11(8):567-577. PubMed ID: 37414069
[TBL] [Abstract][Full Text] [Related]
14. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study.
Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Kelly T; Irvine K; Peters C; Zhyzhneuskaya S; Hollingsworth KG; Adamson AJ; Sniehotta FF; Mathers JC; McIlvenna Y; Welsh P; McConnachie A; McIntosh A; Sattar N; Taylor R
Lancet Diabetes Endocrinol; 2024 Apr; 12(4):233-246. PubMed ID: 38423026
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial.
Ramachandran A; Snehalatha C; Ram J; Selvam S; Simon M; Nanditha A; Shetty AS; Godsland IF; Chaturvedi N; Majeed A; Oliver N; Toumazou C; Alberti KG; Johnston DG
Lancet Diabetes Endocrinol; 2013 Nov; 1(3):191-8. PubMed ID: 24622367
[TBL] [Abstract][Full Text] [Related]
16. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
[TBL] [Abstract][Full Text] [Related]
17. Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Johansen MY; MacDonald CS; Hansen KB; Karstoft K; Christensen R; Pedersen M; Hansen LS; Zacho M; Wedell-Neergaard AS; Nielsen ST; Iepsen UW; Langberg H; Vaag AA; Pedersen BK; Ried-Larsen M
JAMA; 2017 Aug; 318(7):637-646. PubMed ID: 28810024
[TBL] [Abstract][Full Text] [Related]
18. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.
; Gregg EW; Jakicic JM; Blackburn G; Bloomquist P; Bray GA; Clark JM; Coday M; Curtis JM; Egan C; Evans M; Foreyt J; Foster G; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jeffery RW; Johnson KC; Kitabchi AE; Knowler WC; Kriska A; Lang W; Lewis CE; Montez MG; Nathan DM; Neiberg RH; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Redmon B; Regensteiner J; Rejeski J; Ribisl PM; Safford M; Stewart K; Trence D; Wadden TA; Wing RR; Yanovski SZ
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):913-921. PubMed ID: 27595918
[TBL] [Abstract][Full Text] [Related]
19. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW; Astrup A; Fujioka K; Greenway F; Lau DCW; Van Gaal L; Ortiz RV; Wilding JPH; Skjøth TV; Manning LS; Pi-Sunyer X;
Lancet; 2017 Apr; 389(10077):1399-1409. PubMed ID: 28237263
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
